Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Cytokine Patterns for Secondary HLH: Experiences from a Single Center

Xiaoyan Feng, Miaomiao Meng, Zhenchang Sun, Xudong Zhang, Lei Zhang, Mingzhi Zhang

Blood (2024) 144 (Supplement 1): 4375.

https://doi.org/10.1182/blood-2024-207671

Published: 2024

Journal Articles

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

Blood (2024) 144 (Supplement 1): 6458.

https://doi.org/10.1182/blood-2024-202107

Published: 2024

Journal Articles

POD 12 As a Robust Prognostic Index in Patients with Angioimmunoblastic T-Cell Lymphoma: A Single-Center Study

Suxiao Li, Xiaoyan Feng, Jieming Zhang, Yunfei Song, Mengke Fan, Qingjiang Chen, Mingzhi Zhang, Xiaolong Wu, Meng Dong, Lijuan Han, Xudong Zhang

Blood (2024) 144 (Supplement 1): 6410.

https://doi.org/10.1182/blood-2024-207198

Published: 2024

Journal Articles

The Synergistic Anticancer Effect of a Combination of Chidamide and Etoposide Against NK/T Cell Lymphoma

Wenting Song, Zhan Chen, Cunzhen Shi, Yuyang Gao, Xiaoyan Feng, Hongwen Li, Zhaoming Li, Mingzhi Zhang

Blood (2021) 138 (Supplement 1): 3987.

https://doi.org/10.1182/blood-2021-151786

Published: 2021

Journal Articles

Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study

Xinran Ma, MSc, Ling Li, Lei Zhang, Xin Li, Xiaorui Fu, Xinhua Wang, PhD, Jingjing Wu, Xudong Zhang, Xiaoyan Feng, Zhiyuan Zhou, Yu Chang, Zhaoming Li, MD PhD, Ken H. Young, Mingzhi Zhang

Blood (2019) 134 (Supplement_1): 2873.

https://doi.org/10.1182/blood-2019-127912

Published: 2019

Journal Articles

Prognostic Value of Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured By 18F-FDG PET-CT in Patients with T-Cell Lymphoblastic Lymphoma

Xiaoyan Feng, Xin Wen, Ling Li, Xin Li, Sun Zhenchang, Lei Zhang, Lugui Qiu, MD PhD, Mingzhi Zhang, MD PhD

Blood (2019) 134 (Supplement_1): 2851.

https://doi.org/10.1182/blood-2019-130091

Published: 2019

Journal Articles

Latent Membrane Protein 1 Contributes to Deficient Cellular Immunity in NKTCL Patients

Xiaoyan Feng, Yue Song, Zhaoming Li, MD PhD, Xudong Zhang, Lugui Qiu, MD PhD, Mingzhi Zhang, MD PhD

Blood (2019) 134 (Supplement_1): 3969.

https://doi.org/10.1182/blood-2019-128622

Published: 2019

Journal Articles

Suppression of Cdc37 Induces BTZ Resistance through XBP1s Mediated Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Lanting LIU, Fengyan Jin, Jiaojiao Guo, An Gang, MD, Xiaoqi Qin, Tao Zhu, Shuhui Deng, Zhang Shuaishuai, MD, Mu Hao, PhD, Xiaoyan Feng, Yan Xu, MD, Wen Zhou, Lugui Qiu, MD

Blood (2017) 130 (Supplement 1): 4350.

https://doi.org/10.1182/blood.V130.Suppl_1.4350.4350

Published: 2017

Journal Articles

Establishing Mouse Models of B-Cell Non-Hodgkin's Lymphoma

Weili Xue, Weiming Li, Yanjie Zhang, Yue Song, Xuan Lan, Zhaoming Li, MDPhD, Xudong Zhang, MDPhD, Ken H. Young, MD PhD, Mingzhi Zhang, Xiaoyan Feng, Guannan Wang, Zhiyuan Zhou, MD PhD, Lisha Lu, Yingjun Wang, PhD, Mengyuan Jin

Blood (2017) 130 (Supplement 1): 5149.

https://doi.org/10.1182/blood.V130.Suppl_1.5149.5149

Published: 2017

Journal Articles

Osteoclasts Promote Immune Suppressive Microenvironment in Multiple Myeloma: Therapeutic Implication

Gang An, MD PhD, Chirag Acharya, Xiaoyan Feng, MD, Kenneth Wen, Mike Zhong, BS, Li Zhang, Nikhil C Munshi, MD, Lugui Qiu, MD, Yu-Tzu Tai, PhD, Kenneth C. Anderson, MD

Blood (2016) 128 (22): 3303.

https://doi.org/10.1182/blood.V128.22.3303.3303

Published: 2016

Journal Articles

Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Reverse Immunosuppression in Multiple Myeloma

Xiaoyan Feng, Chirag Acharya, MD, Gang An, MD PhD, Kenneth Wen, Li Zhang, Alireza Kalbasi, Lugui Qiu, MD, Nikhil C Munshi, MD, Yu-Tzu Tai, PhD, Kenneth C. Anderson, MD

Blood (2016) 128 (22): 2106.

https://doi.org/10.1182/blood.V128.22.2106.2106

Published: 2016

Journal Articles

Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication

Gang An, Chirag Acharya, Xiaoyan Feng, Kenneth Wen, Mike Zhong, Li Zhang, Nikhil C. Munshi, Lugui Qiu, Yu-Tzu Tai, Kenneth C. Anderson

Blood (2016) 128 (12): 1590–1603.

https://doi.org/10.1182/blood-2016-03-707547

Published: 2016

Includes: Supplemental data

Journal Articles

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment

Yu-Tzu Tai, Chirag Acharya, Gang An, Michele Moschetta, Mike Y. Zhong, Xiaoyan Feng, Michele Cea, Antonia Cagnetta, Kenneth Wen, Hans van Eenennaam, Andrea van Elsas, Lugui Qiu, Paul Richardson, Nikhil Munshi, Kenneth C. Anderson

Blood (2016) 127 (25): 3225–3236.

https://doi.org/10.1182/blood-2016-01-691162

Published: 2016

Includes: Supplemental data

Journal Articles

Activation of Lysosomal Function and Reactive Oxygen Species Play Crucial Roles in SAR650984-Induced Direct Killing of Human Multiple Myeloma Cells with Mutated p53, Which Is Further Augmented By Pomalidomide

Hua Jiang, MDPhD, Chirag Acharya, MD, Gang An Gang An, MDPhD, Xiaoyan Feng, MD, Zhili Song, Guang Yang, PhD, Francisco Adrian, Lugui Qiu, MD, Paul Richardson, MD, Nikhil C. Munshi, MD, Yu-Tzu Tai, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 4253.

https://doi.org/10.1182/blood.V126.23.4253.4253

Published: 2015

Journal Articles

Clonal Evolution Paths Significantly Impact the Outcome of Myeloma

Xiaoqi Qin, MD, Gang An, MDPhD, Lin-ping Hu, MD, Yu Qin, MD PhD, Yan Xu, MDPhD, Xiaoyan Feng, Meirong Zang, Shuhui Deng, MD PhD, Weiwei Sui, MD, Shuhua Yi, MD PhD, Zengjun Li, Sr., Lin-hua Yang, MD, Tao Cheng, MD, Jianxiang Wang, MD, Lugui Qiu, MD PhD

Blood (2015) 126 (23): 1784.

https://doi.org/10.1182/blood.V126.23.1784.1784

Published: 2015

Journal Articles

APRIL/B Cell Maturation Antigen (BCMA) Signaling Cascades Promote Human Multiple Myeloma Growth and Mediate Immunosuppression in the Bone Marrow Microenvironment Via IL-10, TGF-b, and PD-L1

Yu-Tzu Tai, PhD, Chirag Acharya, MD, Gang An, MDPhD, Michele Moschetta, MD, Mike Zhong, BS, Xiaoyan Feng, MD, Hans van Eenennaam, PhD, Andrea van Elsas, PhD, Lugui Qiu, MD PhD, Nikhil C. Munshi, MD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 1810.

https://doi.org/10.1182/blood.V126.23.1810.1810

Published: 2015

Journal Articles

Voriconazole Increase the Risk of PN in Multiple Myeloma Patients Treated with Bortezomib-Based Chemotherapy

Yan Xu, MDPhD, Shuhui Deng, MD, Gang An, MDPhD, Zengjun Li, Sr., Xiaoqi Qin, MD, Weiwei Sui, MD, Xiaoyan Feng, Dehui Zou, Lugui Qiu, MD PhD

Blood (2015) 126 (23): 5394.

https://doi.org/10.1182/blood.V126.23.5394.5394

Published: 2015

Journal Articles

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Fengyan Jin, Lanting Liu, Gang An, MDPhD, Xiaoqi Qin, MD, Xiaoyan Feng, Yan Xu, MDPhD, Mu Hao, MD PhD, Wen Zhou, PhD, Lugui Qiu, MD PhD

Blood (2015) 126 (23): 2480.

https://doi.org/10.1182/blood.V126.23.2480.2480

Published: 2015

Journal Articles

Unmeasurable Serum M-Protein Multiple Myeloma Benefit Less from Bortezomib Than Measurable Myeloma

Xiaoqi Qin, Gang An, MD PhD, Yan Xu, MD PhD, Yu Qin, PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD

Blood (2014) 124 (21): 2062.

https://doi.org/10.1182/blood.V124.21.2062.2062

Published: 2014

Journal Articles

Clonal Heterogeneityand Evolutional Paths in Multiple Myeloma Revealed By QM-FISH in Single Cell of Sequential Analysis

Xiaoqi Qin, Gang An, MD PhD, Yu Qin, PhD, Yan Xu, MD PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD PhD

Blood (2014) 124 (21): 3395.

https://doi.org/10.1182/blood.V124.21.3395.3395

Published: 2014

NARROW

Cytokine Patterns for Secondary HLH: Experiences from a Single Center

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

POD 12 As a Robust Prognostic Index in Patients with Angioimmunoblastic T-Cell Lymphoma: A Single-Center Study

The Synergistic Anticancer Effect of a Combination of Chidamide and Etoposide Against NK/T Cell Lymphoma

Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study

Prognostic Value of Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured By 18F-FDG PET-CT in Patients with T-Cell Lymphoblastic Lymphoma

Latent Membrane Protein 1 Contributes to Deficient Cellular Immunity in NKTCL Patients

Suppression of Cdc37 Induces BTZ Resistance through XBP1s Mediated Plasma Cell Immaturation in Multiple Myeloma

Establishing Mouse Models of B-Cell Non-Hodgkin's Lymphoma

Osteoclasts Promote Immune Suppressive Microenvironment in Multiple Myeloma: Therapeutic Implication

Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Reverse Immunosuppression in Multiple Myeloma

Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment

Activation of Lysosomal Function and Reactive Oxygen Species Play Crucial Roles in SAR650984-Induced Direct Killing of Human Multiple Myeloma Cells with Mutated p53, Which Is Further Augmented By Pomalidomide

Clonal Evolution Paths Significantly Impact the Outcome of Myeloma

APRIL/B Cell Maturation Antigen (BCMA) Signaling Cascades Promote Human Multiple Myeloma Growth and Mediate Immunosuppression in the Bone Marrow Microenvironment Via IL-10, TGF-b, and PD-L1

Voriconazole Increase the Risk of PN in Multiple Myeloma Patients Treated with Bortezomib-Based Chemotherapy

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Unmeasurable Serum M-Protein Multiple Myeloma Benefit Less from Bortezomib Than Measurable Myeloma

Clonal Heterogeneityand Evolutional Paths in Multiple Myeloma Revealed By QM-FISH in Single Cell of Sequential Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only